{
  "id": 7288041,
  "title": "Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.",
  "url": "https://urgent.news/2026/09/14/novartis-just-shook-up-a-multibillion-dollar-drug-race-what-it-means-7288041",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-14T09:04:00.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/novartis-just-shook-multibillion-dollar-drug-race-what-it-means-eli-lilly-stock"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsNovartis recently announced bad news for its Lp(a)-lowering drug, pelacarsen.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.",
        "url": "https://urgent.news/2026/09/14/novartis-just-shook-up-a-multibillion-dollar-drug-race-what-it-means",
        "published": "2026-09-14T08:44:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}